High intestinal and systemic levels of interleukin-23/T-helper 17 pathway in Chinese patients with inflammatory bowel disease

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Song, Lu ^a   Zhou, Rui ^a,b   Huang, Sha ^a   Zhou, Feng ^a   Xu, Shufang ^a   Wang, Wei ^a   Yi, Fengming ^a   Wang, Xiaobing ^a   Xia, Bing ^a,b  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b Key Laboratory of Allergy and Immune Related Disease   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; IL23R PROTEIN, HUMAN; INTERLEUKIN 12P40; INTERLEUKIN 23; INTERLEUKIN RECEPTOR; JAK2 PROTEIN, HUMAN; JANUS KINASE 2; TNFSF15 PROTEIN, HUMAN; VASCULAR ENDOTHELIAL GROWTH INHIBITOR;

ADOLESCENT; ADULT; AGED; ARTICLE; ASIAN; BLOOD; CHILD; CHINA; CROHN DISEASE; CYTOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HUMAN; INTESTINE; MALE; METABOLISM; MIDDLE AGED; TH17 CELL; ULCERATIVE COLITIS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; BIOLOGICAL MARKERS; CHILD; CHINA; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; GENE EXPRESSION REGULATION; GENOTYPE; HUMANS; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-23; INTESTINES; JANUS KINASE 2; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, INTERLEUKIN; TH17 CELLS; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15; YOUNG ADULT;

EID: 84893842826     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/425915     Document Type: Article

References (40)

1. Bouma G., Strober W., The immunological and genetic basis of inflammatory bowel disease. Nature Reviews Immunology 2003 3 7 521 533 2-s2.0-0142053206 10.1038/nri1132 (Pubitemid 37328672)
2. Lees C. W., Barrett J. C., Parkes M., Satsangi J., New IBD genetics: common pathways with other diseases. Gut 2011 60 12 1739 1753 2-s2.0-80655149205 10.1136/gut.2009.199679
3. Silverberg M. S., Cho J. H., Rioux J. D., McGovern D. P. B., Wu J., Annese V., Achkar J.-P., Goyette P., Scott R., Xu W., Barmada M. M., Klei L., Daly M. J., Abraham C., Bayless T. M., Bossa F., Griffiths A. M., Ippoliti A. F., Lahaie R. G., Latiano A., Paré P., Proctor D. D., Regueiro M. D., Steinhart A. H., Targan S. R., Schumm L. P., Kistner E. O., Lee A. T., Gregersen P. K., Rotter J. I., Brant S. R., Taylor K. D., Roeder K., Duerr R. H., Ulcerative colitis-risk loci on chromosomes 1p36 and 12q15 found by genome-wide association study. Nature Genetics 2009 41 2 216 220 2-s2.0-59149087627 10.1038/ng.275
4. Parkes M., Barrett J. C., Prescott N. J., Tremelling M., Anderson C. A., Fisher S. A., Roberts R. G., Nimmo E. R., Cummings F. R., Soars D., Drummond H., Lees C. W., Khawaja S. A., Bagnall R., Burke D. A., Todhunter C. E., Ahmad T., Onnie C. M., McArdle W., Strachan D., Bethel G., Bryan C., Lewis C. M., Deloukas P., Forbes A., Sanderson J., Jewell D. P., Satsangi J., Mansfield J. C., Cardon L., Mathew C. G., Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nature Genetics 2007 39 7 830 832 2-s2.0-34347338690 10.1038/ng2061 (Pubitemid 47014496)
5. Thiébaut R., Kotti S., Jung C., Merlin F., Colombel J. F., Lemann M., Almer S., Tysk C., O'Morain M., Gassull M., Binder V., Finkel Y., Pascoe L., Hugot J.-P., TNFSF15 polymorphisms are associated with susceptibility to inflammatory bowel disease in a new European cohort. The American Journal of Gastroenterology 2009 104 2 384 391 2-s2.0-59749094752 10.1038/ajg.2008.36
6. Ng S. C., Tsoi K. K., Kamm M. A., Genetics of inflammatory bowel disease in Asia: systematic review and meta-analysis. Inflammatory Bowel Diseases 2012 18 6 1164 1176 10.1002/ibd.21845
7. Chen Z., Brant S. R., Li C., Shrestha U. K., Jiang T., Zhou F., Jiang Y., Shi X., Zhao Y., Li J., Xia B., CTLA4-1661A/G and 3′UTR long repeat polymorphisms are associated with ulcerative colitis and influence CTLA4 mRNA and protein expression. Genes and Immunity 2010 11 7 573 583 2-s2.0-77958152209 10.1038/gene.2010.16
8. Duerr R. H., Taylor K. D., Brant S. R., Rioux J. D., Silverberg M. S., Daly M. J., Steinhart A. H., Abraham C., Regueiro M., Griffiths A., Dassopoulos T., Bitton A., Yang H., Targan S., Datta L. W., Kistner E. O., Schumm L. P., Lee A. T., Gregersen P. K., Barmada M. M., Rotter J. I., Nicolae D. L., Cho J. H., A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006 314 5804 1461 1463 2-s2.0-33845340501 10.1126/science.1135245 (Pubitemid 44871953)
9. Brand S., Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut 2009 58 8 1152 1167 2-s2.0-67650224449 10.1136/gut.2008.163667
10. Abraham C., Cho J., Interleukin-23/Th17 pathways and inflammatory bowel disease. Inflammatory Bowel Diseases 2009 15 7 1090 1100 2-s2.0-67449147595 10.1002/ibd.20894
11. Parham C., Chirica M., Timans J., Vaisberg E., Travis M., Cheung J., Pflanz S., Zhang R., Singh K. P., Vega F., To W., Wagner J., O'Farrell A.-M., McClanahan T., Zurawski S., Hannum C., Gorman D., Rennick D. M., Kastelein R. A., De Waal Malefyt R., Moore K. W., A receptor for the heterodimeric cytokine IL-23 is composed of IL-12R β 1 and a novel cytokine receptor subunit, IL-23R. Journal of Immunology 2002 168 11 5699 5708 2-s2.0-0036604306 (Pubitemid 34556153)
12. Langrish C. L., McKenzie B. S., Wilson N. J., de Waal Malefyt R., Kastelein R. A., Cua D. J., IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunological Reviews 2004 202 96 105 2-s2.0-9644291539 10.1111/j.0105-2896.2004.00214.x (Pubitemid 39576907)
13. Anderson C. A., Boucher G., Lees C. W., Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nature Genetics 2011 43 3 246 252 10.1038/ng.764
14. Anderson C. A., Massey D. C., Barrett J. C., Investigation of Crohn's disease risk loci in ulcerative colitis further defines their molecular relationship. Gastroenterology 2009 136 2 523 529 10.1053/j.gastro.2008.10.032
15. Best W. R., Becktel J. M., Singleton J. W., Kern F. Jr., Development of a Crohn's disease activity index. National cooperative Crohn's disease study. Gastroenterology 1976 70 3 439 444 2-s2.0-0017227303
16. Bamias G., Mishina M., Nyce M., Ross W. G., Kollias G., Rivera-Nieves J., Pizarro T. T., Cominelli F., Role of TL1A and its receptor DR3 in two models of chronic murine ileitis. Proceedings of the National Academy of Sciences of the United States of America 2006 103 22 8441 8446 2-s2.0-33744791820 10.1073/pnas.0510903103 (Pubitemid 43838474)
17. Zwiers A., Kraal L., van de Pouw Kraan T. C., Wurdinger T., Bouma G., Kraal G., Cutting edge: a variant of the IL-23R gene associated with inflammatory bowel disease induces loss of microRNA regulation and enhanced protein production. Journal of Immunology 2012 188 4 1573 1577 2-s2.0-84856894610 10.4049/jimmunol.1101494
18. Jürgens M., Laubender R. P., Hartl F., Weidinger M., Seiderer J., Wagner J., Wetzke M., Beigel F., Pfennig S., Stallhofer J., Schnitzler F., Tillack C., Lohse P., Göke B., Glas J., Ochsenkühn T., Brand S., Disease activity, ANCA, and IL23R genotype status determine early response to infliximab in patients with ulcerative colitis. The American Journal of Gastroenterology 2010 105 8 1811 1819 2-s2.0-77955426386 10.1038/ajg.2010.95
19. Silverberg M. S., Satsangi J., Ahmad T., Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Canadian Journal of Gastroenterology 2005 19 supplement A 5A 36A
20. Truelove S. C., Witts L. J., Cortisone in ulcerative colitis; final report on a therapeutic trial. British Medical Journal 1955 2 4947 1041 1048 2-s2.0-0008690916
21. Livak K. J., Schmittgen T. D., Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods 2001 25 4 402 408 2-s2.0-0035710746 10.1006/meth.2001.1262 (Pubitemid 34164012)
22. Shimozato O., Ugai S.-I., Chiyo M., Takenobu H., Nagakawa H., Wada A., Kawamura K., Yamamoto H., Tagawa M., The secreted form of the p40 subunit of interleukin (IL)-12 inhibits IL-23 functions and abrogates IL-23-mediated antitumour effects. Immunology 2006 117 1 22 28 2-s2.0-33644830150 10.1111/j.1365-2567.2005.02257.x
23. McCarroll S. A., Huett A., Kuballa P., Chilewski S. D., Landry A., Goyette P., Zody M. C., Hall J. L., Brant S. R., Cho J. H., Duerr R. H., Silverberg M. S., Taylor K. D., Rioux J. D., Altshuler D., Daly M. J., Xavier R. J., Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nature Genetics 2008 40 9 1107 1112 2-s2.0-50449091647 10.1038/ng.215
24. Asano K., Matsushita T., Umeno J., Hosono N., Takahashi A., Kawaguchi T., Matsumoto T., Matsui T., Kakuta Y., Kinouchi Y., Shimosegawa T., Hosokawa M., Arimura Y., Shinomura Y., Kiyohara Y., Tsunoda T., Kamatani N., Iida M., Nakamura Y., Kubo M., A genome-wide association study identifies three new susceptibility loci for ulcerative colitis in the Japanese population. Nature Genetics 2009 41 12 1325 1329 2-s2.0-70649086082 10.1038/ng.482
25. McGovern D. P., Gardet A., Törkvist L., Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nature Genetics 2010 42 4 332 337 10.1038/ng.549
26. Kim D. J., Kim K. S., Song M. Y., Delivery of IL-12p40 ameliorates DSS-induced colitis by suppressing IL-17A expression and inflammation in the intestinal mucosa. Clinical Immunology 2012 144 3 190 199
27. Sato K., Suematsu A., Okamoto K., Yamaguchi A., Morishita Y., Kadono Y., Tanaka S., Kodama T., Akira S., Iwakura Y., Cua D. J., Takayanagi H., Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. Journal of Experimental Medicine 2006 203 12 2673 2682 2-s2.0-33751521013 10.1084/jem.20061775 (Pubitemid 44833343)
28. Uhlig H. H., McKenzie B. S., Hue S., Thompson C., Joyce-Shaikh B., Stepankova R., Robinson N., Buonocore S., Tlaskalova-Hogenova H., Cua D. J., Powrie F., Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 2006 25 2 309 318 2-s2.0-33747089041 10.1016/j.immuni.2006.05.017
29. Migone T.-S., Zhang J., Luo X., Zhuang L., Chen C., Hu B., Hong J. S., Perry J. W., Chen S.-F., Zhou J. X. H., Cho Y. H., Ullrich S., Kanakaraj P., Carrell J., Boyd E., Olsen H. S., Hu G., Pukac L., Liu D., Ni J., Kim S., Gentz R., Feng P., Moore P. A., Ruben S. M., Wei P., TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 2002 16 3 479 492 2-s2.0-18344385475 10.1016/S1074-7613(02)00283-2 (Pubitemid 34260924)
30. Kamada N., Hisamatsu T., Honda H., Kobayashi T., Chinen H., Takayama T., Kitazume M. T., Okamoto S., Koganei K., Sugita A., Kanai T., Hibi T., TL1A produced by lamina propria macrophages induces Th1 and Th17 immune responses in cooperation with IL-23 in patients with Crohn's disease. Inflammatory Bowel Diseases 2010 16 4 568 575 2-s2.0-77949514515 10.1002/ibd.21124
31. Bamias G., Kaltsa G., Siakavellas S. I., Papaxoinis K., Zampeli E., Michopoulos S., Zouboulis-Vafiadis I., Ladas S. D., High intestinal and systemic levels of decoy receptor 3 (DcR3) and its ligand TL1A in active ulcerative colitis. Clinical Immunology 2010 137 2 242 249 2-s2.0-77957302227 10.1016/j.clim.2010.07.001
32. Bamias G., Martin C. III, Marini M., Hoang S., Mishina M., Ross W. G., Sachedina M. A., Friel C. M., Mize J., Bickston S. J., Pizarro T. T., Wei P., Cominelli F., Expression, localization, and functional activity of TL1A, a novel Th1-polarizing cytokine in inflammatory bowel disease. Journal of Immunology 2003 171 9 4868 4874 2-s2.0-10744225786 (Pubitemid 37310609)
33. Kugathasan S., Baldassano R. N., Bradfield J. P., Sleiman P. M. A., Imielinski M., Guthery S. L., Cucchiara S., Kim C. E., Frackelton E. C., Annaiah K., Glessner J. T., Santa E., Willson T., Eckert A. W., Bonkowski E., Shaner J. L., Smith R. M., Otieno F. G., Peterson N., Abrams D. J., Chiavacci R. M., Grundmeier R., Mamula P., Tomer G., Piccoli D. A., Monos D. S., Annese V., Denson L. A., Grant S. F. A., Hakonarson H., Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nature Genetics 2008 40 10 1211 1215 2-s2.0-52949091918 10.1038/ng.203
34. Franke A., Balschun T., Karlsen T. H., Hedderich J., May S., Lu T., Schuldt D., Nikolaus S., Rosenstiel P., Krawczak M., Schreiber S., Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis. Nature Genetics 2008 40 6 713 715 2-s2.0-44349173654 10.1038/ng.148 (Pubitemid 351748866)
35. Wang K., Zhang H., Kugathasan S., Annese V., Bradfield J. P., Russell R. K., Sleiman P. M. A., Imielinski M., Glessner J., Hou C., Wilson D. C., Walters T., Kim C., Frackelton E. C., Lionetti P., Barabino A., Van Limbergen J., Guthery S., Denson L., Piccoli D., Li M., Dubinsky M., Silverberg M., Griffiths A., Grant S. F. A., Satsangi J., Baldassano R., Hakonarson H., Diverse genome-wide association studies associate the IL12/IL23 pathway with Crohn disease. The American Journal of Human Genetics 2009 84 3 399 405 2-s2.0-61549115034 10.1016/j.ajhg.2009.01.026
36. Noble C. L., Abbas A. R., Lees C. W., Cornelius J., Toy K., Modrusan Z., Clark H. F., Arnott I. D., Penman I. D., Satsangi J., Diehl L., Characterization of intestinal gene expression profiles in Crohn's disease by genome-wide microarray analysis. Inflammatory Bowel Diseases 2010 16 10 1717 1728 2-s2.0-78649253708 10.1002/ibd.21263
37. Liu Z., Yadav P. K., Xu X., Su J., Chen C., Tang M., Lin H., Yu J., Qian J., Yang P.-C., Wang X., The increased expression of IL-23 in inflammatory bowel disease promotes intraepithelial and lamina propria lymphocyte inflammatory responses and cytotoxicity. Journal of Leukocyte Biology 2011 89 4 597 606 2-s2.0-79953703986 10.1189/jlb.0810456
38. Yen D., Cheung J., Scheerens H., Poulet F., McClanahan T., Mckenzie B., Kleinschek M. A., Owyang A., Mattson J., Blumenschein W., Murphy E., Sathe M., Cua D. J., Kastelein R. A., Rennick D., IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. Journal of Clinical Investigation 2006 116 5 1310 1316 2-s2.0-33646397611 10.1172/JCI21404
39. Sugimoto K., Ogawa A., Mizoguchi E., Shimomura Y., Andoh A., Bhan A. K., Blumberg R. S., Xavier R. J., Mizoguchi A., IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. Journal of Clinical Investigation 2008 118 2 534 544 2-s2.0-38849141814 10.1172/JCI33194 (Pubitemid 351206544)
40. Kolls J. K., Lindén A., Interleukin-17 family members and inflammation. Immunity 2004 21 4 467 476 2-s2.0-5644277476 10.1016/j.immuni. 2004.08.018 (Pubitemid 39370503)